Published in Pediatrics on October 01, 2000
Diagnosis of community-acquired pertussis infection: comparison of both culture and fluorescent-antibody assays with PCR detection using electrophoresis or dot blot hybridization. J Clin Microbiol (2002) 0.87
Relative trends in hospitalizations and mortality among infants by the number of vaccine doses and age, based on the Vaccine Adverse Event Reporting System (VAERS), 1990-2010. Hum Exp Toxicol (2012) 0.84
Combination vaccines. J Glob Infect Dis (2011) 0.81
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS). Vaccine (2015) 0.81
Febrile seizures. Korean J Pediatr (2014) 0.78
Identification of peptides that mimic the pertussis toxin binding site on bovine fetuin. Appl Environ Microbiol (2003) 0.75
Background rates of disease in Latin American children from a rotavirus vaccine study. Hum Vaccin Immunother (2017) 0.75
Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med (1995) 20.53
Calcium-channel blockade and incidence of cancer in aged populations. Lancet (1996) 8.04
Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg (1985) 7.14
Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues. Ann Intern Med (2000) 5.06
Do calcium channel blockers increase the risk of cancer? Am J Hypertens (1996) 4.75
Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA (2000) 4.36
Impact of anti-vaccine movements on pertussis control: the untold story. Lancet (1998) 4.18
Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measles. JAMA (1999) 3.77
Randomized phase II clinical trials. Cancer Treat Rep (1985) 3.19
Disability as a public health outcome in the aging population. Annu Rev Public Health (1996) 3.02
Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials. N Engl J Med (1990) 2.97
Does influenza vaccination prevent asthma exacerbations in children? J Pediatr (2001) 2.89
Serum albumin level and physical disability as predictors of mortality in older persons. JAMA (1994) 2.66
Prevalence of antibody to HIV-1 among entrants to US correctional facilities. JAMA (1991) 2.51
Low cholesterol concentrations and severe depressive symptoms in elderly people. BMJ (1994) 2.51
HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA (1995) 2.46
The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med (1998) 2.46
Projections of AIDS morbidity and mortality in San Francisco. JAMA (1990) 2.42
Cognitive impairment and risk of stroke in the older population. J Am Geriatr Soc (1996) 2.32
Fatal respiratory disease due to Corynebacterium diphtheriae: case report and review of guidelines for management, investigation, and control. Clin Infect Dis (1993) 2.21
The renal effects of nonsteroidal anti-inflammatory drugs in older people: findings from the Established Populations for Epidemiologic Studies of the Elderly. J Am Geriatr Soc (1999) 2.12
Safety of revaccination with pneumococcal polysaccharide vaccine. JAMA (1999) 2.09
Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop. Control Clin Trials (2001) 2.06
Confounding in studies of adverse reactions to vaccines. Am J Epidemiol (1992) 2.06
Progressive versus catastrophic disability: a longitudinal view of the disablement process. J Gerontol A Biol Sci Med Sci (1996) 1.95
Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med (1997) 1.85
The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med (2001) 1.84
Processes for obtaining nonmedical exemptions to state immunization laws. Am J Public Health (2001) 1.83
Physical activity and risk of severe gastrointestinal hemorrhage in older persons. JAMA (1994) 1.79
Stevens-Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the vaccine adverse event reporting system. Pediatr Infect Dis J (2001) 1.60
Injection safety: a global challenge. Bull World Health Organ (1999) 1.52
The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States. Am J Public Health (1997) 1.50
Diphtheria in the United States, 1971-81. Am J Public Health (1985) 1.44
Postlicensure safety surveillance for varicella vaccine. JAMA (2000) 1.44
Hair loss after routine immunizations. JAMA (1997) 1.43
Board certification among preventive medicine residency graduates: characteristics, advantages, and barriers. Am J Prev Med (1995) 1.39
Pertussis--a disease and a vaccine that are not going away. West J Med (1989) 1.35
An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group. Vaccine (1999) 1.23
Negative association between MMR and autism. Lancet (1999) 1.20
Influenza vaccination in children with asthma in health maintenance organizations. Vaccine Safety Datalink Team. Vaccine (2000) 1.19
Advanced age a risk factor for illness temporally associated with yellow fever vaccination. Emerg Infect Dis (2001) 1.19
The complicated task of monitoring vaccine safety. Public Health Rep (1997) 1.19
A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer. J Clin Oncol (1987) 1.19
The incidence of Kawasaki syndrome in West Coast health maintenance organizations. Pediatr Infect Dis J (2000) 1.17
Population-based study of rotavirus vaccination and intussusception. Pediatr Infect Dis J (2001) 1.17
A two-stage design for choosing among several experimental treatments and a control in clinical trials. Biometrics (1989) 1.16
Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination. Am J Epidemiol (2001) 1.13
An efficient design for phase III studies of combination chemotherapies. Cancer Treat Rep (1985) 1.13
Principles of measles control. Bull World Health Organ (1991) 1.13
Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU). N Engl J Med (1983) 1.12
Low-dose heparin for prevention of venous thromboembolism in total hip arthroplasty and surgical repair of hip fractures. J Bone Joint Surg Am (1978) 1.06
Addressing the challenges to immunization practice with an economic algorithm for vaccine selection. Vaccine (1998) 1.03
Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors. Vaccine (2001) 1.03
Two-year review of hepatitis A vaccine safety: data from the Vaccine Adverse Event Reporting System (VAERS). Clin Infect Dis (1998) 1.03
New designs for the selection of treatments to be tested in randomized clinical trials. Stat Med (1994) 1.02
Cumulative incidence of childhood-onset IDDM is unaffected by pertussis immunization. Diabetes Care (1997) 1.01
Epidemiology of diarrheal disease among children enrolled in four West Coast health maintenance organizations. Vaccine Safety Datalink Team. Pediatr Infect Dis J (1998) 1.00
Outbreak of pyogenic abscesses after diphtheria and tetanus toxoids and pertussis vaccination. Pediatr Infect Dis J (1993) 1.00
Randomization designs in comparative clinical trials. N Engl J Med (1984) 0.97
Respiratory diphtheria in the United States, 1980 through 1995. Am J Public Health (1998) 0.95
Risk factors for fatal heart attack in young women. Am J Epidemiol (1981) 0.95
Serum albumin and physical function as predictors of coronary heart disease mortality and incidence in older persons. J Clin Epidemiol (1996) 0.94
Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics (2001) 0.94
Surrogate endpoints. Br J Cancer (1993) 0.93
Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system. Pediatrics (2001) 0.92
Proactive safety surveillance. Pharmacoepidemiol Drug Saf (2001) 0.91
Anaphylaxis from yellow fever vaccine. J Allergy Clin Immunol (1999) 0.90
Hospital and nursing home use in the last three months of life. J Aging Health (1996) 0.90
Medical care behind bars: Maryland prison system. Md Med J (1989) 0.90
Serum iron level, coronary artery disease, and all-cause mortality in older men and women. Am J Cardiol (1997) 0.90
Utility of large-linked databases in vaccine safety, particularly in distinguishing independent and synergistic effects. The Vaccine Safety Datalink Investigators. Ann N Y Acad Sci (1995) 0.90
Effect of age and severity of disability on short-term variation in walking speed: the Women's Health and Aging Study. J Clin Epidemiol (1996) 0.89
On the use of laboratory markers as surrogates for clinical endpoints in the evaluation of treatment for HIV infection. J Acquir Immune Defic Syndr (1990) 0.88
Measuring vaccine efficacy from epidemics of acute infectious agents. Stat Med (1993) 0.87
[Distribution of 14C labeled at dioxopiperazine or methyl morpholine group of probimane by whole body autoradiography]. Zhongguo Yao Li Xue Bao (1993) 0.87
Autism and measles-mumps-rubella vaccination: controversy laid to rest? CNS Drugs (2001) 0.87
Antidepressant use in the elderly: association with demographic characteristics, health-related factors, and health care utilization. J Clin Epidemiol (1995) 0.87
Optimal two-stage designs for clinical trials with binary response. Stat Med (1988) 0.86
Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Vaccine Safety Datalink Team. Arch Fam Med (2000) 0.86
Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS Working Group. Vaccine (2000) 0.86
Alcohol consumption and risk of deep venous thrombosis and pulmonary embolism in older persons. J Am Geriatr Soc (1996) 0.85
Automated external defibrillators. N Engl J Med (2001) 0.85
The epidemiology of fatalities reported to the vaccine adverse event reporting system 1990-1997. Pharmacoepidemiol Drug Saf (2001) 0.83
Surrogate end points in clinical trials. BMJ (1991) 0.83
Vertebral abnormalities associated with synthetic retinoid use. J Am Acad Dermatol (1984) 0.83
Safety of neonatal hepatitis B vaccine administration. Pediatr Infect Dis J (2001) 0.83
Syncope after immunization. Arch Pediatr Adolesc Med (1997) 0.83
The data and safety monitoring board and acquired immune deficiency syndrome (AIDS) clinical trials. Control Clin Trials (1995) 0.82
Comparative safety of two recombinant hepatitis B vaccines in children: data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD). J Clin Epidemiol (1998) 0.82
Safety data on meningococcal polysaccharide vaccine from the Vaccine Adverse Event Reporting System. Clin Infect Dis (2001) 0.81
Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Pediatrics (2001) 0.81
Disability and severe gastrointestinal hemorrhage. A prospective study of community-dwelling older persons. J Am Geriatr Soc (1994) 0.81